Skip to main content
SpringerLink
Log in

ASO Author Reflections: Total Parietal Peritonectomy During Interval Cytoreductive Surgery for Advanced Ovarian Cancer—Proof-of-Principle and Analysis of Morbidity

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hynninen J, Lavonius M, Oksa S, et al. Is perioperative visual estimation of intra- abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy? Gynecol Oncol. 2013;128:229–32.

    Article  Google Scholar 

  2. Sinukumar S, Rajan F, Mehta S, Damodaran D, Zaveri S, Kammar P, et al. A comparison of outcomes following total and selective peritonectomy performed at the time of interval cytoreductive surgery for advanced serous epithelial ovarian, fallopian tube and primary peritoneal cancer: a study by INDEPSO. Eur J Surg Oncol. 2019. pii: S0748-7983(19)30304-X. https://doi.org/10.1016/j.ejso.2019.02.031.

  3. Lim MC, Song YJ, Seo SS, Yoo CW, Kang S, Park SY. Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer. Onkologie. 2010;33(6):324–30. https://doi.org/10.1159/000313823.

    Article  PubMed  Google Scholar 

  4. Bhatt A, Kammar P, Sinukumar S, Parikh L, Jumale N, Shaikh S, et al. Total parietal peritonectomy can be performed with acceptable morbidity in patients with advanced ovarian cancer following neoadjuvant chemotherapy: results from a prospective multi-centric study. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08918-4.

  5. Di Giorgio A, De Iaco P, De Simone M, et al. Cytoreduction (peritonectomy procedures) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in advanced ovarian cancer: retrospective Italian multi-center observational study of 511 cases. Ann Surg Oncol. 2017;24:914–22.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Zydus Hospital, Thaltej, Ahmedabad, 380054, India

    Aditi Bhatt MS, MCh.

  2. Department of Surgical Oncology, Saifee Hospital, Mumbai, India

    Praveen Kammar MS, MCh. & Sanket Mehta DNB

  3. Department of Surgical Oncology, Jehangir Hospital, Pune, India

    Snita Sinukumar MS, MCh.

Authors
  1. Aditi Bhatt MS, MCh.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Praveen Kammar MS, MCh.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sanket Mehta DNB
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Snita Sinukumar MS, MCh.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aditi Bhatt MS, MCh..

Ethics declarations

Disclosure

The authors have no disclosures.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhatt, A., Kammar, P., Mehta, S. et al. ASO Author Reflections: Total Parietal Peritonectomy During Interval Cytoreductive Surgery for Advanced Ovarian Cancer—Proof-of-Principle and Analysis of Morbidity. Ann Surg Oncol 27 (Suppl 3), 861–862 (2020). https://doi.org/10.1245/s10434-020-08940-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08940-6

Search

Navigation